Allergan announced it will establish an R&D presence in the Kendall Square section of Cambridge, Massachusetts.
The drugmaker says the new, strategic presence in Kendall Square will allow them to more easily interact and engage with venture firms and start ups in the area. The facility will be led by Don Frail, senior vice president of research and external scientific innovation and non-clinical translational sciences.
The new Cambridge group will be fully integrated with the Allergan organization, and serve as a portal to other R&D sites in Madison NJ, San Francisco area, and globally.
